Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.

2014-05-01/in Barouch

Teigler JE, Kagan JC, Barouch DH. Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity. J. Virol. 2014; 88:10354-10363. [Article]

Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity.

Center for Virology and Vaccine Research

CVVR Clinical Trials Unit

Affiliates